Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Peripheral Artery Disease (PAD)

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

Home November 14, 2019
Home
News | Drug-Eluting Balloons

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

Home November 14, 2019
Home
News | Atherectomy Devices

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
News | Endovascular Aortic Repair

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

Home November 11, 2019
Home
News | Stents Carotid

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

Home November 11, 2019
Home
News

November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...

Home November 08, 2019
Home
News

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

Home November 08, 2019
Home
News | Vascular Access

November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed ...

Home November 07, 2019
Home
News | Stents Bioresorbable

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

Home November 07, 2019
Home
News | Drug-Eluting Balloons

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

Home November 07, 2019
Home
News | Atherectomy Devices

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

Home November 07, 2019
Home
News

November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...

Home November 06, 2019
Home
Edwards Sapien 3 TAVI Granted European Approval to Treat Low-risk Patients. TAVR cleared for low risk patients in Europe
Feature

November 6, 2019 — Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3 ...

Home November 06, 2019
Home
Subscribe Now